ALDEYRA THERAPEUTICS INC
ALDX · NASDAQ
Updated at 2026-10-14 09:20:46
- Today's High
- $0.91
- Today’s Low
- $0.86
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.92
- Previous Close
- $0.90
- Volume
- 1.34M
- Market Cap
- $54.64M
- P/E Ratio
- --
- EPS
- $-0.38
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 131 HARTWELL AVENUE, LEXINGTON, MA, UNITED STATES, 02421
- Country
- US
- Listing Date
- 2014-05-02
- Fiscal Year End
- December
- Shares Outstanding
- 60.32M
- CIK
- 0001341235
- Website
- www.aldeyra.com
Aldeyra Therapeutics, Inc., a biotechnology company, develops and markets drugs for immune-mediated systemic and eye diseases. The company is headquartered in Lexington, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$5.85M
2026-03-31
$3.48M
2025-12-31
$6.66M
2025-09-30
$8M
Net Income
2026-06-30
-$5.45M
2026-03-31
-$3.45M
2025-12-31
-$6.46M
2025-09-30
-$7.68M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.16
2026-03-31
$-0.06
2025-12-31
$-0.11
2025-09-30
$-0.13
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$5.37M
2026-03-31
-$2.91M
2025-12-31
-$5.92M
2025-09-30
-$7.14M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $5.85M | $3.48M | $6.66M | $8M |
| Net Income | -$5.45M | -$3.45M | -$6.46M | -$7.68M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.16 | $-0.06 | $-0.11 | $-0.13 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$5.37M | -$2.91M | -$5.92M | -$7.14M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.